Aeterna Zentaris
AEZS
#10128
Rank
A$24.6 M
Marketcap
A$8.04
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2024 (TTM): A-$3.11

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is A-$2.88. In 2022 the company made an earnings per share (EPS) of A-$6.58 a decrease over its 2021 EPS that were of A-$2.56.

EPS history for Aeterna Zentaris from 1998 to 2024

Annual EPS

Year EPS Change
2024 (TTM)A-$3.11
2022A-$6.58157.14%
2021A-$2.56-41.48%
2020A-$4.37-64.46%
2019A-$12.29-240%
2018A$8.78-122.32%
2017A-$39.34-53.53%
2016A-$84.65-86.71%
2015A-$637.17-35.21%
2014A-$983.50-216.67%
2013A$843.00-123.3%
2012A-$3,618-40.8%
2011A-$6,112-6.45%
2010A-$6,533-27.91%
2009A-$9,062-61.61%
2008A-$23,60483.61%
2007A-$12,856-195.31%
2006A$13,488178.26%
2005A$4,847-330%
2004A-$2,107-80.05%
2003A-$10,56417.78%
2002A-$8,969515.93%
2001A-$1,456-68.6%
2000A-$4,638119.62%
1999A-$2,112-3.63%
1998A-$2,191

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
A$10.34-459.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
A$2.90-200.79%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$4.17-244.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
A-$0.51-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
A$6.87-338.66%๐Ÿ‡บ๐Ÿ‡ธ USA